Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2008 · fourth_quarter · Q4
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Source: Senate LDA
Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Secure Visa Waiver Travel Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Secure Visa Waiver Travel Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Secure Visa Waiver Travel Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Food and Drug Administration Amendments Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Food and Drug Administration Amendments Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Food and Drug Administration Amendments Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Food and Drug Administration Amendments Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Saving Our Community Pharmacies Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Saving Our Community Pharmacies Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Saving Our Community Pharmacies Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Saving Our Community Pharmacies Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Fair Medicaid Drug Payment Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Fair Medicaid Drug Payment Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Fair Medicaid Drug Payment Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Fair Medicaid Drug Payment Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Safeguarding America's Pharmaceuticals Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Safeguarding America's Pharmaceuticals Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Safeguarding America's Pharmaceuticals Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare Improvements for Patients and Providers Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Medicare Improvements for Patients and Providers Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare Improvements for Patients and Providers Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
PRO(TECH)T Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
PRO(TECH)T Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
PRO(TECH)T Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Community Protection and Response Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Community Protection and Response Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Wired for Health Care Quality Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Wired for Health Care Quality Act
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Fair Medicaid Drug Payment Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Fair Medicaid Drug Payment Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Fair Medicaid Drug Payment Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Fair Medicaid Drug Payment Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Pharmacy Access Improvement (PhAIm) Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Pharmacy Access Improvement (PhAIm) Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Pharmacy Access Improvement (PhAIm) Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Pharmacy Access Improvement (PhAIm) Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare, Medicaid, and SCHIP Extension Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare, Medicaid, and SCHIP Extension Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare, Medicaid, and SCHIP Extension Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Medicare Prescription Drug Price Negotiation Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Food and Drug Administration Amendments Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; potential pharmacist compounding amendments to HR 2900 and HR 3580, the "Food and Drug Administration Amendments Act of 2007"; CMS-2238-P and CMS-2238-FC, the proposed and final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005;
Food and Drug Administration Amendments Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; potential pharmacist compounding amendments to HR 2900 and HR 3580, the "Food and Drug Administration Amendments Act of 2007"; CMS-2238-P and CMS-2238-FC, the proposed and final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005;
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; potential pharmacist compounding amendments to HR 2900 and HR 3580, the "Food and Drug Administration Amendments Act of 2007"; CMS-2238-P and CMS-2238-FC, the proposed and final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005;
Community Pharmacy Fairness Act of 2007
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; potential pharmacist compounding amendments to HR 2900 and HR 3580, the "Food and Drug Administration Amendments Act of 2007"; CMS-2238-P and CMS-2238-FC, the proposed and final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005;
A bill to state the policy of the United States on the intercontinental ballistic missile force.
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S1931 HR4241 Medicaid Medicare S440 HR1671 HR390 HR595
A bill to amend title XIX of the Social Security Act to include podiatrists as physicians for purposes of covering physicians services under the medicaid program.
Client: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION · Firm: NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
S1931 HR4241 Medicaid Medicare S440 HR1671 HR390 HR595
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2008 · third_quarter · Q3
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2008 · second_quarter · Q2
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2008 · first_quarter · Q1
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2007 · year_end · YY
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; potential pharmacist compounding amendments to HR 2900 and HR 3580, the "Food and Drug Administration Amendments Act of 2007"; CMS-2238-P and CMS-2238-FC, the proposed and final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA)
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2006 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2005 · year_end · YY
S1931 HR4241 Medicaid Medicare S440 HR1671 HR390 HR595
Filing targets: Administration on Aging, Agency for Healthcare Research & Quality (AHRQ), Agency for Toxic Substances & Disease Registry, Bureau of Alcohol Tobacco Firearms & Explosives, Bureau of Citizenship & Immigration Services (BCIS), Bureau of Economic Analysis, Bureau of Indian Affairs (BIA), Bureau of Justice Statistics, Bureau of Transportation Statistics, Bureau of the Census, Employment Standards Administration, Federal Election Commission (FEC), Federal Management Service, General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Natl Indian Gaming Commission, Office of Government Ethics (OGE), Office of the Vice President of the United States, President of the U.S., SENATE, Technology Administration, Treasury, Dept of, Veterans Affairs, Dept of (VA)
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2005 · year_end · RR
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2005 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA)
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION via NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
2005 · mid_year · RA